ACCESSION: MSBNK-SMB_Measured-HSA015P0284000
RECORD_TITLE: Annotated; Octadecanamide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 53
COMMENT: RAW_SPEC {'EL03_pos_10491': {'bp': 1218583.0, 'sum': 2947470.0}, 'Blanc1-pos_10867': {'bp': 962676.0, 'sum': 2186389.0}, 'EL03_pos_10549': {'bp': 639681.0, 'sum': 1631161.0}, 'EL19_pos_10629': {'bp': 447105.0, 'sum': 1020832.0}, 'EL14_pos_10557': {'bp': 411810.0, 'sum': 930522.0}, 'EL04_pos_10527': {'bp': 374244.0, 'sum': 826087.0}, 'EL18_pos_10533': {'bp': 369859.0, 'sum': 814851.0}, 'EL02_pos_10631': {'bp': 357085.0, 'sum': 875040.0}, 'EL21_pos_10569': {'bp': 344517.0, 'sum': 844700.0}, 'EL17_pos_10563': {'bp': 339617.0, 'sum': 810975.0}, 'EL13_pos_10557': {'bp': 334197.0, 'sum': 768307.0}, 'EL24_pos_10540': {'bp': 334008.0, 'sum': 799740.0}, 'EL16_pos_10539': {'bp': 309048.0, 'sum': 753338.0}, 'EL01_pos_10529': {'bp': 294009.0, 'sum': 727119.0}, 'EL10_pos_10529': {'bp': 286649.0, 'sum': 664874.0}, 'EL20_pos_10545': {'bp': 280344.0, 'sum': 695303.0}, 'EL15_pos_10576': {'bp': 277367.0, 'sum': 734067.0}, 'EL22_pos_10659': {'bp': 274639.0, 'sum': 772881.0}, 'EL06_pos_10577': {'bp': 266134.0, 'sum': 705395.0}, 'EL08_pos_10539': {'bp': 249894.0, 'sum': 668961.0}, 'Blanc2-pos_10455': {'bp': 248140.0, 'sum': 612271.0}, 'EL09_pos_10552': {'bp': 239770.0, 'sum': 620282.0}, 'EL05_pos_10611': {'bp': 236914.0, 'sum': 650030.0}, 'EL23_pos_10551': {'bp': 221596.0, 'sum': 579667.0}, 'Blanc3-pos_10467': {'bp': 218248.0, 'sum': 591265.0}, 'EL11_pos_10534': {'bp': 214385.0, 'sum': 568013.0}, 'EL07_pos_10540': {'bp': 210616.0, 'sum': 565236.0}, 'Blanc1-pos_10921': {'bp': 195063.0, 'sum': 686777.0}, 'EL02_pos_10690': {'bp': 181245.0, 'sum': 529718.0}, 'EL21_pos_10631': {'bp': 177969.0, 'sum': 482483.0}, 'EL17_pos_10624': {'bp': 169971.0, 'sum': 444578.0}, 'EL06_pos_10642': {'bp': 167850.0, 'sum': 494620.0}, 'EL13_pos_10619': {'bp': 162786.0, 'sum': 448527.0}, 'EL15_pos_10643': {'bp': 162654.0, 'sum': 457818.0}, 'EL23_pos_10612': {'bp': 158864.0, 'sum': 423196.0}, 'EL19_pos_10691': {'bp': 158781.0, 'sum': 474263.0}, 'EL22_pos_10714': {'bp': 158684.0, 'sum': 510540.0}, 'EL20_pos_10605': {'bp': 158668.0, 'sum': 454899.0}, 'EL01_pos_10588': {'bp': 157563.0, 'sum': 440941.0}, 'EL12_pos_10582': {'bp': 156693.0, 'sum': 489155.0}, 'EL14_pos_10619': {'bp': 156123.0, 'sum': 421094.0}, 'EL12_pos_10641': {'bp': 151085.0, 'sum': 457520.0}, 'EL16_pos_10600': {'bp': 150478.0, 'sum': 456085.0}, 'EL09_pos_10612': {'bp': 148758.0, 'sum': 440791.0}, 'EL18_pos_10587': {'bp': 144708.0, 'sum': 426918.0}, 'EL24_pos_10601': {'bp': 142694.0, 'sum': 394102.0}, 'EL04_pos_10583': {'bp': 141397.0, 'sum': 422470.0}, 'EL10_pos_10589': {'bp': 138541.0, 'sum': 385229.0}, 'EL07_pos_10600': {'bp': 135103.0, 'sum': 383759.0}, 'EL11_pos_10593': {'bp': 129885.0, 'sum': 396032.0}, 'EL08_pos_10594': {'bp': 126244.0, 'sum': 397706.0}, 'EL05_pos_10665': {'bp': 114815.0, 'sum': 368888.0}, 'Blanc3-pos_10528': {'bp': 112031.0, 'sum': 365467.0}}
COMMENT: RETENTION_TIME_STDEV 0.052
COMMENT: PRECURSOR_M/Z_RAW 284.294891
COMMENT: PRECURSOR_M/Z_STDEV 0.000085
COMMENT: PRECURSOR_IN_MS1 mz 284.294889; int 52.523; delta(ppm) 1.389897
COMMENT: PROPOSED_CHARGE_STATE +1; mz 285.298368; int 10.075; cor 0.869
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.349; C18H37NO; [M+H]+; delta(ppm) 0.349468
COMMENT: PROPOSED_MF MS-FINDER 3.443; C18H37NO; [M+H]+; delta(ppm) 0.347380
COMMENT: PROPOSED_MF SIRIUS5_Sirius 32.685; C18H37NO; [M+H]+; delta(ppm) 0.347380
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C18H37NO; [M+H]+; delta(ppm) 0.347380
COMMENT: PROPOSED_MF SIRIUS6_Sirius 46.767; C18H37NO; [M+H]+; delta(ppm) 0.347380
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.230; C16H35N4; [M+H]+; delta(ppm) 5.070191
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C18H37NO; [M+H]+; delta(ppm) 0.347380
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 15.000; LYRFLYHAGKPMFH-UHFFFAOYSA-N; C18H37NO; Spectral Match to Octadecanamide from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; QGVZKRVVGPWPNA-UHFFFAOYSA-N; C18H37NO; amylamine-C13:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.357; LYRFLYHAGKPMFH-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.154; HNOAUFBMSISHIO-AGDOHHJYNA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)[C@H](C)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.141; MYTDNGUQXKUHFN-UHFFFAOYSA-N; [M+H]+; O=C(NCC)CCCCCCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.135; ZREXGWPJFRJAJU-SWESGNQDSA-N; [M+H]+; CCCCCCCCCCCCCC=CC(C(C)N)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.096; OOBSUSUFVSSVFU-UHFFFAOYSA-N; [M+H]+; CCOCCCCCCC=CCCCCCCCCN
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.650; LYRFLYHAGKPMFH-UHFFFAOYSA-N; [M+H]+; Octadecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.573; ZREXGWPJFRJAJU-SWESGNQDSA-N; [M+H]+; (E,2S,3R)-2-aminooctadec-4-en-3-ol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.427; SBUKOHLFHYSZNG-UHFFFAOYNA-N; [M+H]+; 4-dodecyl-2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.405; ZFZYQMQYEVIHMY-UHFFFAOYNA-N; [M+H]+; 4-dodecyl-2,5-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.375; NHIPIGXCJWQVRH-UHFFFAOYSA-N; [M+H]+; CNP0439307
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.309; MYTDNGUQXKUHFN-UHFFFAOYSA-N; [M+H]+; N-ethylhexadecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.289; USBSYOMZAJVNGA-UHFFFAOYSA-N; [M+H]+; N-hexyldodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.262; HNOAUFBMSISHIO-AGDOHHJYNA-N; [M+H]+; 1-deoxy-3-dehydrosphinganine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.181; OOBSUSUFVSSVFU-UHFFFAOYSA-N; [M+H]+; ethoxylated amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZREXGWPJFRJAJU-SWESGNQDSA-N; [M+H]+; (E,2S,3R)-2-aminooctadec-4-en-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.859; LYRFLYHAGKPMFH-UHFFFAOYSA-N; [M+H]+; Octadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.859; HNOAUFBMSISHIO-AGDOHHJYNA-N; [M+H]+; 1-deoxy-3-dehydrosphinganine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.859; MYTDNGUQXKUHFN-UHFFFAOYSA-N; [M+H]+; N-ethylhexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.763; NHIPIGXCJWQVRH-UHFFFAOYSA-N; [M+H]+; CNP0439307
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.758; ZFZYQMQYEVIHMY-UHFFFAOYNA-N; [M+H]+; 4-dodecyl-2,5-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.756; SBUKOHLFHYSZNG-UHFFFAOYNA-N; [M+H]+; 4-dodecyl-2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.738; USBSYOMZAJVNGA-UHFFFAOYSA-N; [M+H]+; N-hexyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.484; OOBSUSUFVSSVFU-UHFFFAOYSA-N; [M+H]+; ethoxylated amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.994; LYRFLYHAGKPMFH-UHFFFAOYSA-N; [M+H]+; octadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.677; SBUKOHLFHYSZNG-UHFFFAOYSA-N; [M+H]+; 4-dodecyl-2,6-dimethylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.530; ZXQPAHCKMPFMTO-UHFFFAOYSA-N; [M+H]+; 1-(2-dodecoxyethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.440; UOYBMZNFJUBBNU-UHFFFAOYSA-N; [M+H]+; N,N-dimethylhexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.394; HNOAUFBMSISHIO-KRWDZBQOSA-N; [M+H]+; (2S)-2-aminooctadecan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.245; WZGQRPGQTOSEMN-UHFFFAOYSA-N; [M+H]+; N-hexadecylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.230; JMJDXDJTXDRLAL-UHFFFAOYSA-N; [M+H]+; 4-tetradecylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.223; KZVIUXKOLXVBPC-UHFFFAOYSA-N; [M+H]+; 16-methylheptadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.067; HYDFMWOGHZZOKE-UHFFFAOYSA-N; [M+H]+; 1-dodecyl-1-oxidoazepan-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -1.070; LYRFLYHAGKPMFH; [M+H]+; Adogen 42
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.857; KZVIUXKOLXVBPC; [M+H]+; Isooctadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -89.051; MYTDNGUQXKUHFN; [M+H]+; N-ethylpalmitamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -94.242; USBSYOMZAJVNGA; [M+H]+; N-hexyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.335; UOYBMZNFJUBBNU; [M+H]+; N,N-Dimethylpalmitamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.430; HNOAUFBMSISHIO; [M+H]+; (2S)-2-amino-3-octadecanone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -182.405; OOBSUSUFVSSVFU; [M+H]+; (E)-16-ethoxyhexadec-9-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.431; JMJDXDJTXDRLAL; [M+H]+; 4-Tetradecylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.634; HYDFMWOGHZZOKE; [M+H]+; 1-dodecyl-1-oxidoazepan-1-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.113; ZREXGWPJFRJAJU; [M+H]+; (E,2S,3R)-2-aminooctadec-4-en-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.185; SBUKOHLFHYSZNG; [M+H]+; Aldimorph
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.505; ZXQPAHCKMPFMTO; [M+H]+; 1-(2-dodecoxyethyl)pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.617; XFUVTDJSLXTNCF; [M+H]+; 4-dodecyl-4-ethylmorpholin-4-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.810; FJQJNVCOIJSMGZ; [M+H]+; (2R,3R,6S)-6-dodecyl-2-methylpiperidin-3-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -279.953; ZFZYQMQYEVIHMY; [M+H]+; Morpholine, 4-dodecyl-2,5-dimethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.927; LYRFLYHAGKPMFH; [M+H]+; Adogen 42
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -107.157; LYRFLYHAGKPMFH; [M+H]+; octadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -162.128; MYTDNGUQXKUHFN; [M+H]+; N-ethylhexadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -191.708; UOYBMZNFJUBBNU; [M+H]+; N,N-Dimethylhexadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.607; RRNKVONILTZEAA; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -200.226; USBSYOMZAJVNGA; [M+H]+; N-hexyldodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.725; JMJDXDJTXDRLAL; [M+H]+; 4-Tetradecylmorpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -234.764; NHIPIGXCJWQVRH; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -237.354; HNOAUFBMSISHIO; [M+H]+; 2-Aminooctadecan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -246.250; HYDFMWOGHZZOKE; [M+H]+; 1H-Azepine, hexahydro-1-dodecyl-, 1-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -264.207; OOBSUSUFVSSVFU; [M+H]+; Oleyl amine ethoxylate (3-50EO)
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.875; LYRFLYHAGKPMFH; [M+H]+; octadecanamide
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Octadecanamide, LYRFLYHAGKPMFH-UHFFFAOYSA-N; Matching to 15 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0034146;
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C18H37NO
CH$EXACT_MASS: 283.287515
CH$SMILES: CCCCCCCCCCCCCCCCCC(=O)N
CH$IUPAC: InChI=1S/C18H37NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H2,19,20)
CH$LINK: CHEBI CHEBI:34900
CH$LINK: HMDB HMDB0034146
CH$NAME: Octadecanamide
CH$NAME: Octadecanamide
CH$NAME: octadecanamide
CH$LINK: INCHIKEY LYRFLYHAGKPMFH-UHFFFAOYSA-N
CH$LINK: LIPIDMAPS LMFA08010003
CH$LINK: PUBCHEM CID:31292
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 17.259
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 284.294890
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-2190000000-63914bf5f71a69703cce
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545022 39.7481 55.055210 0.8174 9.65 0.8243 51 f{C4H7}/5.01ppm,p-C14H31N1O1
  57.0701535 125.4912 57.070870 0.4381 15.60 0.9613 53 f{C4H9}/4.85ppm,p-C14H29N1O1
  67.0543785 16.5393 67.055120 1.4466 5.67 0.6680 49 f{C5H7}/2.26ppm,p-C13H31N1O1
  69.0700170 54.1489 69.070760 0.8832 13.20 0.8370 53 f{C5H9}/2.03ppm,p-C13H29N1O1
  74.0601287 30.6910 74.060870 1.1612 13.31 0.8743 40 f{C3H8N1O1}/1.19ppm,p-C15H30
  81.0699436 25.4819 81.070670 0.8758 9.24 0.6461 46 f{C6H9}/0.83ppm,p-C12H29N1O1
  83.0856106 34.2803 83.086330 0.9508 8.14 0.8580 51 f{C6H11}/1.01ppm,p-C12H27N1O1
  85.1012539 17.6494 85.101965 1.3983 4.61 0.8052 44 f{C6H13}/0.91ppm,p-C12H25N1O1
  88.0757532 90.0914 88.076450 0.7948 48.84 0.8792 51 f{C4H10N1O1}/0.71ppm,p-C14H28
  95.0855476 26.4780 95.086200 1.0832 10.10 0.6699 48 f{C7H11}/0.22ppm,p-C11H27N1O1
  97.1012131 23.5864 97.101850 1.1740 6.09 0.8267 45 f{C7H13}/0.37ppm,p-C11H25N1O1
  102.0914116 56.5963 102.092005 0.8424 20.19 0.9205 50 f{C5H12N1O1}/0.70ppm,p-C13H26
  116.1070358 24.6051 116.107510 1.4039 4.14 0.9012 43 f{C6H14N1O1}/0.39ppm,p-C12H24
  134.0964744 119.4142 134.096760 0.7159 48.60 0.0348 53 f{C9H12N1}/0.36ppm,p-C9H26O1
  135.0999770 44.2576 135.100250 1.1621 19.98 -0.2567 50 ?
  282.2216842 158.2956 282.222080 0.7122 65.98 0.0046 53 ?
  282.2787141 35.4533 282.279110 1.7394 14.98 0.4838 39 f{C18H36N1O1}/-1.51ppm,p-H2
  283.2251934 227.0203 283.225590 0.7591 91.57 -0.2598 49 ?
  284.2947726 999.0000 284.295170 0.3658 0.00 1.0000 53 f{C18H38N1O1}/-0.07ppm,p
  285.2980918 155.3943 285.298490 0.8307 11.48 0.9855 50 ?
PK$NUM_PEAK: 20
PK$PEAK: m/z int. rel.int.
  55.054502 39.75 39
  57.070154 125.49 125
  67.054378 16.54 16
  69.070017 54.15 54
  74.060129 30.69 30
  81.069944 25.48 25
  83.085611 34.28 34
  85.101254 17.65 17
  88.075753 90.09 90
  95.085548 26.48 26
  97.101213 23.59 23
  102.091412 56.60 56
  116.107036 24.61 24
  134.096474 119.41 119
  135.099977 44.26 44
  282.221684 158.30 158
  282.278714 35.45 35
  283.225193 227.02 227
  284.294773 999.00 999
  285.298092 155.39 155
//
